Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What was the loe of treximet in the us?What's the impact of lipitor on cholesterol and protein in the elderly?Febuxostat sales in usa?Febuxostat patent expiry gout?Imipramine pamoate price?
See the DrugPatentWatch profile for Tezspire
Tezspire (tezepelumab) is a targeted medicine for severe asthma. It is used to reduce asthma exacerbations in patients with severe asthma, including those whose asthma is not fully controlled by existing therapies. [1]
Tezspire is a biologic (tezepelumab) designed to block thymic stromal lymphopoietin (TSLP), an upstream signal that contributes to airway inflammation. By blocking TSLP, it helps reduce inflammatory processes that drive asthma flares. [1]
Tezspire is administered as an injection under the skin (subcutaneous). [1]
Tezspire is made by AstraZeneca. [1]
For patent and exclusivity-related tracking, DrugPatentWatch.com lists Tezspire (tezepelumab) with information focused on its patent landscape. You can use it to check what patents or exclusivities may still be in force and when generic or biosimilar entry could become possible. [2]
[1] https://www.tevadesir.com/tezeprie [2] https://www.drugpatentwatch.com/p/tezspire
Other Questions About Tezspire :